In July 2023, we changed our name from AACC (short for the American Association for Clinical Chemistry) to the Association for Diagnostics & Laboratory Medicine (ADLM). The following page links to resources that were written prior to the rebranding and/or mentions events that took place prior to the rebranding and that contain mentions of the association’s old name.
AACC continually tracks legislative and regulatory issues of importance to clinical laboratories and the clinical laboratory profession. This is a listing of AACC's 2015 comment letters. AACC commented on a wide range of topics to federal and state authorities.
2015 Legislative and regulatory issues
AACC Proposes Broadening PAMA Reporting Requirements
NOV.24.2015
AACC Raises Concerns About Expanded FDA Oversight of LDTs
NOV.17.2015
AACC joined with the Friends of AHRQ in opposing cuts in AHRQ spending
OCT.22.2015
AACC endorsed legislation to assist young researchers obtain NIH grants
SEP.03.2015
AACC joined with other groups in supporting funding for an alternative National Children’s Study
AUG.25.2015
AACC provided input to NIH on its new Environmental Influences on Child Health Outcomes Program
AUG.14.2015
AACC joined the Friends of AHRQ in opposing cuts in agency funding
JUL.13.2015
JUL.01.2015
AACC endorsed H.R.1190, the Protecting Seniors' Access to Medicare Act of 2015
JUN.02.2015
AACC endorsed the Next Generation Researchers Act
MAY.29.2015
AACC recommended CMS Establish a Transition Period for Expanded Blood Glucose Monitor Oversight
MAY.04.2015
AACC joins the Friends of AHRQ in supporting federal funding for AHRQ
MAR.23.2015
MAR.16.2015
AACC urged FDA to maintain current oversight structure for next generation sequencing testing
MAR.16.2015AACC urged the FDA to maintain the existing regulatory structure for LDTs
JAN.29.2015
AACC provided input regarding the FDA’s notification and medical device reporting proposals for LDTs
JAN.29.2015
AACC and others urged NIH to spend National Children’s Study funds on pediatric research
JAN.21.2015
AACC endorsed H.R.160, the Protect Medical Innovation Act
JAN.14.2015
AACC endorsed S.141, the Protecting Seniors’ Access to Medicare Act
JAN.14.2015
AACC provided testimony at the FDA Workshop on the regulation of LDTs
JAN.08.2015
AACC provided input to the House Energy and Commerce Committee regarding LDTS
JAN.05.2015